COVID-19 Crowding Out Non-COVID-19 Healthcare And Drug Development

The world is tackling the acute crisis of the COVID-19 pandemic with as many resources as possible. With already over 3.7 million confirmed cases and 260,000 deaths worldwide over a relatively short time span, COVID-19 has placed an inordinate burden on healthcare systems. Hospitals have had to reprogram - and in some cases temporarily close - care units to accommodate COVID-19 patients. Research institutes and pharmaceutical firms have shut down many `non-essential’ activities in favor of work on the novel coronavirus.